Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Apogee Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/21/2023 |
4
| McKenna Mark C. (Director) has filed a Form 4 on Apogee Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $23.6, valued at
$1.2M
Granted 100,000 options to buy
@ $23.6, valued at
$2.4M
|
|
| 07/17/2023 |
4
| Gottesdiener Andrew (Director) has filed a Form 4 on Apogee Therapeutics, Inc.|
Txns:
| Granted 47,758 options to buy
@ $17, valued at
$811.9k
|
|
| 07/17/2023 |
4
| Shah Nimish P (Director) has filed a Form 4 on Apogee Therapeutics, Inc.|
Txns:
| Bought 1,750,000 shares
@ $17, valued at
$29.8M
Granted 47,758 options to buy
@ $17, valued at
$811.9k
|
|
| 07/17/2023 |
4
| Fairmount Funds Management LLC (Director) has filed a Form 4 on Apogee Therapeutics, Inc.|
Txns:
| Bought 55,913 shares
@ $17, valued at
$950.5k
Bought 1,992,734 shares
@ $17, valued at
$33.9M
Bought 892,529 shares
@ $17, valued at
$15.2M
Granted 47,758 options to buy
@ $17, valued at
$811.9k
|
|
|
|